We're excited to announce that Lucinda Hittle has joined our Board of Advisors!
Lucinda earned her B.S. in Chemistry from Indiana University and completed her Ph.D. in Analytical Chemistry at the University of Pittsburgh in 1994. She brings over three decades of experience in the pharmaceutical and biotechnology sectors, with expertise in drug metabolism, pharmacokinetics and bioanalytical sciences. She has held senior roles at industry-leading companies such as Pfizer, Merck and Kallyope, Inc., and has contributed to the development of several marketed drugs, including Ibrance™, Noxafil™ and Lagevrio™.
Currently the President of Discovery & Development Insights, LLC, Lucinda’s vast knowledge in drug discovery and development along with her leadership within scientific organizations like the American Society for Mass Spectrometry (ASMS), will be invaluable as we continue to innovate and expand in the life sciences industry.
We are thrilled to have Lucinda on board and look forward to the insights and expertise she brings to our team.
コメント